Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial

ConclusionLM50 achieved better overall glycemic control than LM25 as a starter insulin in Chinese patients, which may be due to greater improvement in PPG levels.Trial RegistrationClinicaltrials.gov identification number: NCT01773473.FundingEli Lilly and Company, Shanghai, China.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research